Key statistics
JCY Bio in numbers.
Every number on this page traces to a single, defendable source. We avoid composite or unverifiable claims.
Platform
Strains, facility and IP
300+
Reserved functional strains
Internal library
>1,000 m²
Laboratory floor area
P2 + GMP facility
80%
Researcher share of headcount
Company composition
100+
IP assets
Strain registrations + patent portfolio
Clinical record & donor safety
What our clinical brand has done
10,000+
FMT & assays performed
Cumulative aFMT operations
5+
World medical records
Including the first global complete remission in Stage IVB pMMR/MSS colorectal cancer (Cureus 2024)
18–25
Donor age band (SDS)
Healthy university-age donors
120+
Donor medical screens
SDS donor-safety system
<2%
Donor acceptance rate
SDS donor-safety system
Evidence & consensus
Where the field stands
4
Expert consensus we contributed to or cited
See /evidence
6.80×
Endoscopic response vs. control in UC
From the UC consensus (2025) — 14 RCTs + ~600-case meta + ~15,000-case Chinese cohort
Source narratives and citations live on Evidence. For methodology questions, use Contact.